Fanconi anemia pathway and its relationship with cancer

نویسندگان

چکیده

Abstract Fanconi Anemia (FA) is a rare inherited hematological disease, caused by mutations in genes involved the DNA interstrand crosslink (ICL) repair. Up to date, 22 have been identified that encode series of functionally associated proteins recognize ICL lesion and mediate activation downstream repair pathway including nucleotide excision repair, translesion synthesis, homologous recombination. The FA strictly regulated complex mechanisms such as ubiquitination, phosphorylation, degradation signals are essential for maintenance genome stability. Here, we summarize discovery history recent advances genes, further discuss role carcinogenesis cancer therapies.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Mutated Fanconi anemia pathway in non-Fanconi anemia cancers

An extremely high cancer incidence and the hypersensitivity to DNA crosslinking agents associated with Fanconi Anemia (FA) have marked it to be a unique genetic model system to study human cancer etiology and treatment, which has emerged an intense area of investigation in cancer research. However, there is limited information about the relationship between the mutated FA pathway and the cancer...

متن کامل

Cancer in Fanconi anemia.

of CMV reactivation were reported by other groups using fludarabine in combination with busulphan, melphalan, or low-dose total body irradiation (TBI) (21%-42%). 5,6 The median time of onset of CMV infection was also beyond 45 days in all these studies. The only other regimen associated with a higher and earlier incidence of CMV infection has been a combination of fludarabine and antilymphocyte...

متن کامل

Exploiting the Fanconi Anemia Pathway for Targeted Anti-Cancer Therapy

Genome instability, primarily caused by faulty DNA repair mechanisms, drives tumorigenesis. Therapeutic interventions that exploit deregulated DNA repair in cancer have made considerable progress by targeting tumor-specific alterations of DNA repair factors, which either induces synthetic lethality or augments the efficacy of conventional chemotherapy and radiotherapy. The study of Fanconi anem...

متن کامل

Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer.

mTOR is a serine/threonine kinase and plays a critical role in mammalian cell growth, survival, and metabolism. mTOR is present in two cellular complexes: mTORC1 and mTORC2. Dysregulation of the mTOR pathway has been related to tumorigenesis, poor prognosis and/or chemotherapy resistance in a variety of malignancies. Inhibition of mTORC1 by Rapamycin and its analogs has been explored to treat a...

متن کامل

The Fanconi Anemia Pathway of Genomic Maintenance

Fanconi anemia (FA), a recessive syndrome with both autosomal and X-linked inheritance, features diverse clinical symptoms, such as progressive bone marrow failure, hypersensitivity to DNA cross-linking agents, chromosomal instability and susceptibility to cancer. At least 12 genetic subtypes have been described (FA-A, B, C, D1, D2, E, F, G, I, J, L, M) and all except FA-I have been linked to a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Genome instability & disease

سال: 2021

ISSN: ['2524-7662']

DOI: https://doi.org/10.1007/s42764-021-00043-0